bovine adrenal medulla peptide 8-22 (Human) [1456]



bovine adrenal medulla peptide 8-22 (Human)


SMILES CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
InChIKey GOEYECACIBFJGZ-NPAGUKBMSA-N
Sequence VGRPEWWMDYQKRYG
HELM PEPTIDE1{V.G.R.P.E.W.W.M.D.Y.Q.K.R.Y.G}$$$$

Chemical Properties

Hydrogen bond acceptors 25
Hydrogen bond donors 29
Rotatable bonds 60
Log P -4.031
Molecular weight (Da) 1969.9
Stereochemistry info unspecified

Database connections

Structure pdb 8DWC 8DWG 8JGF 8JGG
Model (AF2) MRGPRX1

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

bovine adrenal medulla peptide 8-22 (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 8DWC 8DWG 8JGF 8JGG
Model (AF2) MRGPRX1

Compound is not listed as a drug.